Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. R1 RCM Inc.
  6. News
  7. Summary
    RCM   US7493971052

R1 RCM INC.

(RCM)
  Report
Delayed Quote. Delayed Nasdaq - 10/20 04:00:00 pm
22.8 USD   +2.06%
10/14INSIDER SELL : R1 Rcm
MT
10/14R1 RCM : JPMorgan Starts R1 RCM at Overweight with $27 Price Target
MT
10/12R1 RCM : to Release Third Quarter 2021 Results on November 2
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

R1 RCM : Announces Appointment of Agnes Bundy Scanlan to Board of Directors (Form 8-K)

08/12/2021 | 04:13pm EDT
R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors
Murray, UT - August 12, 2021 - R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021.
Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Treliant LLC from 2017 to 2020 and from 2012 to 2015, prior to which she was the northeast regional director at the Consumer Financial Protection Bureau from 2015 to 2017. From 2009 until 2011, Ms. Bundy Scanlan served as the chief regulatory officer, chief compliance officer and global chief privacy officer at TD Bank. In addition, Ms. Bundy Scanlan practiced law at Goodwin Procter LLP from 2005 to 2009 and held various C-Suite roles at Bank of America and FleetBoston Financial from 1994 to 2004. From 1989 until 1993, Ms. Bundy Scanlan was counsel at the United States Senate Budget Committee. Ms. Bundy Scanlan also serves on the boards of AppFolio, Inc., New Tower Trust, and Truist Financial Corporation.
'We are very pleased to welcome Agnes to our board,' said Alex Mandl, lead director of R1's board. 'Agnes brings a strong background in regulatory risk and compliance management and legal experience to the board through her years of proven leadership across several organizations. I look forward to working with her and driving continued success for R1.'
'As we continue to build R1's scale and breadth of solutions, we are confident that Agnes's experience, expertise and guidance will provide valuable perspectives as we continue to execute our strategy and strive to deliver high-quality outcomes for our customers,' said Joe Flanagan, president and chief executive officer of R1.

'I am excited to join R1's board of directors,' said Ms. Bundy Scanlan. 'R1 serves a critical function in a highly regulated industry, and I look forward to contributing my perspectives to drive the company's important mission and success.'


About R1 RCM
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1's proven and scalable operating models seamlessly complement a healthcare organization's infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.
R1 RCM Contacts:
Investor Relations:
Atif Rahim
312.324.5476
investorrelations@r1rcm.com

Media Relations:
Natalie Joslin
678.585.1206
media@r1rcm.com

Disclaimer

R1 RCM Inc. published this content on 12 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2021 20:11:10 UTC.


© Publicnow 2021
All news about R1 RCM INC.
10/14INSIDER SELL : R1 Rcm
MT
10/14R1 RCM : JPMorgan Starts R1 RCM at Overweight with $27 Price Target
MT
10/12R1 RCM : to Release Third Quarter 2021 Results on November 2
AQ
09/30R1 RCM : Barclays Starts R1 RCM at Overweight With $28 Price Target
MT
08/31R1 RCM : to Present at Upcoming Investor Conferences
AQ
08/12R1 RCM : Announces Appointment of Agnes Bundy Scanlan to Board of Directors (Form 8-K)
PU
08/12R1 RCM INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
AQ
08/12R1 RCM : Announces Appointment of Agnes Bundy Scanlan to Board of Directors
AQ
08/12R1 RCM Inc. Announces Appointment of Agnes Bundy Scanlan to its Board of Directors
CI
08/09R1 RCM : Introduces Entri™ Platform to Comprehensively Transform Patient Access and ..
AQ
More news
Analyst Recommendations on R1 RCM INC.
More recommendations
Financials (USD)
Sales 2021 1 467 M - -
Net income 2021 112 M - -
Net Debt 2021 626 M - -
P/E ratio 2021 -22,9x
Yield 2021 -
Capitalization 6 358 M 6 358 M -
EV / Sales 2021 4,76x
EV / Sales 2022 4,15x
Nbr of Employees 19 600
Free-Float 46,1%
Chart R1 RCM INC.
Duration : Period :
R1 RCM Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends R1 RCM INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 22,80 $
Average target price 31,90 $
Spread / Average Target 39,9%
EPS Revisions
Managers and Directors
Joseph Gerard Flanagan President, Chief Executive Officer & Director
Rachel Wilson Chief Financial Officer, Treasurer & Executive VP
Jay Sreedharan Chief Technology & Digital Officer
Julia K. Davis Chief Information Officer & Executive VP
John Sparby COO, Executive VP-Operations & Delivery
Sector and Competitors